This study is being done to find the best dose of an investigational drug called NBM-BMX for people with metastatic uveal melanoma, a type of eye cancer that h…

Metastatic Uveal MelanomaUveal Melanoma, MetastaticUveal Melanoma, Recurrent+2 more

~Estimated

~$10 – $8,750

Novelwise Pharmaceutical CorporationNCT07136181

Phase 1

A Phase 1 Dose-Escalation and Expansion Study of Intratumorally Administered ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas

A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dos…

Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more

~Estimated

~$10 – $8,750

OncoNano Medicine, Inc.NCT06022029